The Discovery of CCR5 Receptor Antagonists for the Treatment of HIV Infection: Hit‐to‐Lead Studies
ChemMedChem2006Vol. 1(7), pp. 706–709
Citations Over Time
Duncan Armour, Marcel J. de Groot, Martin P. Edwards, Manos Perros, David A. Price, Blanda Stammen, Anthony Wood
Abstract
The discovery of UK-374,503 started from a high-throughput screening hit that was a potent Type II P450 2D6 inhibitor and which displayed no antiviral activity. The optimisation of affinity for the CCR5 receptor while reducing concerns about P450 inhibition and the subsequent introduction of antiviral effects were key milestones for the project.
Related Papers
- → Marine Natural Product Libraries for High-Throughput Screening and Rapid Drug Discovery(2008)143 cited
- → Drug Discovery Goes Three-Dimensional: Goodbye to Flat High-Throughput Screening?(2015)77 cited
- → ARQiv-HTS, a versatile whole-organism screening platform enabling in vivo drug discovery at high-throughput rates(2016)50 cited
- → Design of Signal Windows in High Throughput Screening Assays for Drug Discovery(1997)63 cited
- → High-Throughput and In Silico Screening in Drug Discovery(2017)10 cited